Date Modified

2023-11-24

Period

6/months

Report Summary

• Trial commenced on 24.05.2023. • Recruitment status: recruiting • Number assessed for eligibility: 60 • Number recruited and allocated/randomized: 48 • Final sample size: Target is 79 patients (including 10% dropouts)

Attached file